Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir Plus Lamivudine for Switch Therapy in Patients with HIV-1 Infection: A Real-World Cohort Study.

Lin GanXiaoxin XieYanhua FuXiaoyan YangShujing MaLinghong KongChunli SongYebing SongTingting RenHai Long

Published in: Infectious diseases and therapy (2023)

Both regimens are well tolerated and effective for switching HIV-1 infection therapy. However, the detection of genotypic drug resistance should be considered when baseline virological non-suppression is observed.

Keyphrases

antiretroviral therapy
hiv infected patients
hiv infected
cell therapy
mesenchymal stem cells
loop mediated isothermal amplification
replacement therapy
smoking cessation